These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 10448934

  • 21. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.
    Ross RA, Brockie HC, Pertwee RG.
    Eur J Pharmacol; 2000 Aug 04; 401(2):121-30. PubMed ID: 10924916
    [Abstract] [Full Text] [Related]

  • 22. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
    Rawls SM, Cabassa J, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 2002 Jun 04; 301(3):963-8. PubMed ID: 12023525
    [Abstract] [Full Text] [Related]

  • 23. Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes.
    Kaplan BL, Rockwell CE, Kaminski NE.
    J Pharmacol Exp Ther; 2003 Sep 04; 306(3):1077-85. PubMed ID: 12805480
    [Abstract] [Full Text] [Related]

  • 24. Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study.
    Petitet F, Jeantaud B, Capet M, Doble A.
    Biochem Pharmacol; 1997 Dec 01; 54(11):1267-70. PubMed ID: 9416978
    [Abstract] [Full Text] [Related]

  • 25. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R, Cabezos PA, Vera G, Fernández-Pujol R, Martín MI.
    Neurogastroenterol Motil; 2010 Jun 01; 22(6):694-e206. PubMed ID: 20132133
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K, Molleman A, Parsons M, Whelan C.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):207-15. PubMed ID: 12620515
    [Abstract] [Full Text] [Related]

  • 27. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.
    Benamar K, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 2008 May 19; 325(2):641-5. PubMed ID: 18281594
    [Abstract] [Full Text] [Related]

  • 28. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
    McAllister SD, Griffin G, Satin LS, Abood ME.
    J Pharmacol Exp Ther; 1999 Nov 19; 291(2):618-26. PubMed ID: 10525080
    [Abstract] [Full Text] [Related]

  • 29. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
    Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS.
    Eur J Pharmacol; 2003 Jan 10; 459(1):83-95. PubMed ID: 12505537
    [Abstract] [Full Text] [Related]

  • 30. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.
    Coruzzi G, Adami M, Coppelli G, Frati P, Soldani G.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec 10; 360(6):715-8. PubMed ID: 10619190
    [Abstract] [Full Text] [Related]

  • 31. AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain.
    Hosohata Y, Quock RM, Hosohata K, Makriyannis A, Consroe P, Roeske WR, Yamamura HI.
    Eur J Pharmacol; 1997 Feb 19; 321(1):R1-3. PubMed ID: 9083796
    [Abstract] [Full Text] [Related]

  • 32. Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways.
    Yoshihara S, Morimoto H, Yamada Y, Abe T, Arisaka O.
    Am J Respir Crit Care Med; 2004 Nov 01; 170(9):941-6. PubMed ID: 15306537
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
    Ihenetu K, Molleman A, Parsons ME, Whelan CJ.
    Eur J Pharmacol; 2003 Jan 01; 458(1-2):207-15. PubMed ID: 12498928
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models.
    Smith SR, Denhardt G, Terminelli C.
    Eur J Pharmacol; 2001 Nov 30; 432(1):107-19. PubMed ID: 11734194
    [Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.
    Iwamura H, Suzuki H, Ueda Y, Kaya T, Inaba T.
    J Pharmacol Exp Ther; 2001 Feb 30; 296(2):420-5. PubMed ID: 11160626
    [Abstract] [Full Text] [Related]

  • 37. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY, D'Agostino B, Risse PA, Marrocco G, Naline E, Zhang Y, Chen HZ, Finance O, Rinaldi-Carmona M, Rossi F, Advenier C.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):206-13. PubMed ID: 17643417
    [Abstract] [Full Text] [Related]

  • 38. Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats.
    Germanò MP, D'Angelo V, Mondello MR, Pergolizzi S, Capasso F, Capasso R, Izzo AA, Mascolo N, De Pasquale R.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb 14; 363(2):241-4. PubMed ID: 11218077
    [Abstract] [Full Text] [Related]

  • 39. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.
    Landsman RS, Burkey TH, Consroe P, Roeske WR, Yamamura HI.
    Eur J Pharmacol; 1997 Sep 03; 334(1):R1-2. PubMed ID: 9346339
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM, Compton DR, Martin BR, Abood ME.
    J Pharmacol Exp Ther; 1996 Sep 03; 278(3):989-99. PubMed ID: 8819477
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.